International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy

Author(s): Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina

Issue: Nov/Dec 2013 - Volume 17, Number 6
View All Articles in Issue

Page(s): 452-457

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 1

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 2

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 3

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 4

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 5

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 6

Download in electronic PDF format for $75

Abstract: Pharmacists must consider all factors when dosing medication for a patient. Until recently, however, one key piece to this puzzle was missing—genetics. This invisible piece of the puzzle can now be utilized with pharmacogenetic testing. By using pharmacogenetic testing, the compounding pharmacist will be able to better predict disease risk as well as the pharmacodynamic and pharmacokinetic actions of the prescriptions their patients are taking. Pharmacogenetics is poised to become the standard of care that not only physicians are embracing, but pharmacists can utilize to better personalize their patient’s needs.

Related Keywords: pharmacogenetics, genetics, genetic testing, personalize, personalization, metabolic pathways, response to therapy, breast cancer risk prediction, hormone replacement therapy, HRT, cytochrome P450, warfarin, gene mutations, single nucleotide polymorphisms

Related Categories: HRT, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, PATIENT ASSESSMENT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina	Nov/Dec 2013 Pg. 452-457
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing Kells John, Dollbaum Charles M	Sep/Oct 2009 Pg. 392-399
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R	Jul/Aug 2011 Pg. 290-300
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Gillson George R, Zava David T	Jul/Aug 2003 Pg. 250-256
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jan/Feb 2015 Pg. 6-12
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation Kells John, Dollbaum Charles M	Jul/Aug 2009 Pg. 280-288
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Ford Gina, Garcia Lea	Jan/Feb 2001 Pg. 52-54
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J	Sep/Oct 2016 Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J	Nov/Dec 2016 Pg. 447-454
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations McElhiney Linda F	Jul/Aug 2013 Pg. 307-311
Bioidentical Hormone Replacement Therapy, Part 2, A Review of Wepfer Scott T	Jan/Feb 2002 Pg. 50-54
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T	Mar/Apr 2002 Pg. 142-146
Microbiologic Testing for 503A Sterile-Compounding Pharmacies Mixon William, Roth Abby	May/Jun 2017 Pg. 193-203
Establishing a Rationale for Compounding Hormone Replacement Therapy Biundo Bruce	May/Jun 2018 Pg. 190-195
Establishing a Rationale for Compounding Hormone Replacement Therapy Biundo Bruce	Jan/Feb 2024 Pg. 22-27
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel	Jul/Aug 2009 Pg. 314-317
Hormone Therapy: It's Time for a Second Opinion Collins Joseph J, Ahlgrimm Maria	Mar/Apr 2008 Pg. 122-127
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 Vu Nicole, Lou Jessica R, Kupiec Thomas C	Jul/Aug 2014 Pg. 305-310
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle Reed-Kane Dana	Nov/Dec 2004 Pg. 412
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M	May/Jun 2006 Pg. 175-183
Return to Top